Tech français consacré aux nouvelles technologies (internet, logiciel, matériel, mobilité, entreprise) et au jeu vidéo PC et consoles.

Cette compétence n’est plus, aujourd’hui, l’apanage des super-héros Marvel. Dans un monde en pleine métamorphose, ...

The tie-up of SpaceX and xAI is all about a plan to dominate space with artificial-intelligence data centers, according to Elon Musk, who founded both companies. It won’t be cheap. Analysts at ...

Executives at DeFi Development (NASDAQ:DFDV) used the company’s monthly business recap and AMA to outline January operational ...

America faces a serious housing shortage, one that Moody’s estimates would take more than 2 million new homes to resolve. But over at Goldman Sachs, analysts put the number at 3 million. Zillow’s ...

Texas Instruments (TXN) shares were up 6.5% during early market trading on Wednesday following its fourth-quarter results and outlook, which proved the data center buildout is benefitting more than ...

Analysts with Wisconsin's utility regulator question if a new rate plan will protect residents from costs tied to data centers. We Energies has proposed a special rate for data centers, which includes ...

About 97% of Wall Street analysts rate Microsoft stock as a buy, the highest percentage among S&P 500 stocks. One of the major growth catalysts for Microsoft is its AI cloud computing business, which ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...

Multiple media outlets, including the Associated Press, reported that ByteDance has reached an agreement with Oracle ORCL, Silver Lake, and Abu-Dhabi-based MGX to set up a joint venture for TikTok’s ...

A company with $20 billion in annual revenue can’t commit $1.4 trillion to capital infrastructure. It’s simple math: by the end of 2026, market pressure is likely to push OpenAI toward scaling back ...

Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...